Gynoveda, a startup that provides Ayurveda-backed healthcare solutions for women, has raised $10M in Series A funding led by India Alternatives Fund. Other participants in the round include several family offices and institutions such as Wipro Enterprises, RPG Ventures, Dharampal Satyapal Ltd, and Alteria Capital. The company’s previous investor, Fireside Ventures, also participated in the round. The startup, founded by Rachana and…
Celmatix, a leading biotech company specializing in ovarian biology for women’s health, has released the findings from a long-term research collaboration with the University of Oxford and 24 other institutions to decode the genetic underpinnings of endometriosis. This condition affects approximately 1 in 10 women worldwide (190 million globally) and has enormous implications for the quality of life. The severe inflammatory condition…
Berlin-based startup theblood has raised close to €1M in pre-seed funding to advance research on menstrual blood analysis and biomarkers as well as the development of a non-invasive blood at-home test that helps menstruators monitor their health. The round was led by RoX Health with participation from Leanox VC and several business angels including HealthHero and Fernarzt Founder Felix Kaiser, Prof. Dr.…
HERMONE, a Berlin-based femtech start-up, has launched the its cycle tracking app after raising €1M in pre-seed funding from angel investors. The app provides easily accessible knowledge about the four phases of the cycle, as well as the hormones that are primarily involved. HERMONE was founded by Lucia Vilsecker and Philippa Zorn in 2021. More than 90 percent of all women experience…
Ahead of International Women’s Day, new preliminary findings from the Apple Women’s Health Study underscore the importance of paying attention to the menstrual cycle and its connection to overall health. Many physicians consider periods a vital sign, yet this area of health is notably under-researched. The Apple Women’s Health Study is a first-of-its-kind research study conducted with the Harvard T.H. Chan School of Public…
Chugai Pharmaceutical and Biofourmis have formed a partnership to develop digital solutions for pain management in patients with endometriosis. The companies have been working together since July 2020 to develop objective assessment of pain associated with the disease, which has resulted in the utilization of Biofourmis’ Biovitals platform for a biosensor and AI-based algorithm. Chugai, headquartered in Tokyo, is a research-based pharmaceutical…
Egal, a company dedicated to achieving equality for periods in restrooms, is launching a new menstrual pad that will be as easily accessible as toilet paper. Despite 300 million people menstruating daily, the unpredictability of periods and lack of access to period products can result in embarrassment, missed work or school. Egal is launching its product with $1 million investment angel funding,…
Endometriosis is a debilitating condition that affects one in ten women of reproductive age, causing excessive bleeding, inflammation, and debilitating pain. The disease occurs when tissue that usually lines the inside of the uterus grows outside the womb and attaches to other organs in the body. The condition can significantly impact a person’s quality of life and their ability to work, study,…
